ZNF284
Zinc finger protein 284
Also known as: DKFZp781F1775, ZN284_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q2VY69
- Gene
- ZNF284
- Ensembl
- ENSG00000186026
- Chromosome
- 19
- Canonical length
- 593 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
593 residues, UniProt reviewed canonical sequence.
>Q2VY69|ZNF284
1 MTMFKEAVTF KDVAVVFTEE ELGLLDVSQR KLYRDVMLEN FRNLLSVGHQ LSHRDTFHFQ
61 REEKFWIMET ATQREGNSGG KIQTELESVP ETGPHEEWSC QQIWEQTASE LTRPQDSISS
121 SQFSTQGDVP SQVDAGLSII HIGETPSEHG KCKKFFSDVS ILDLHQQLHS GKISHTCNEY
181 RKRFCYSSAL CLHQKVHMGE KRYKCDVCSK AFSQNSQLQT HQRIHTGEKP FKCEQCGKSF
241 SRRSGMYVHC KLHTGEKPHI CEECGKAFIH NSQLREHQRI HTGEKPFKCY ICGKSFHSRS
301 NLNRHSMVHM QEKSFRCDTC SNSFGQRSAL NSHCMDHTKE KLYKCEECGR SFTCRQDLCK
361 HQMDHTGDKP YNCNVCGKGF RWSSCLSRHQ RVHNGETTFK CDGCGKRFYM NSQGHSHQRA
421 YREEELYKCQ KCGKGYISKF NLDLHQRVHT GERPYNCKEC GKSFRWASGI LRHKRLHTGE
481 KPFKCEECGK RFTENSKLRF HQRIHTGEKP YKCEECGKGF RWASTHLTHQ RLHSREKLFQ
541 CEDCGKSSEH SSCLQDQQSD HSGEKTSKCE DCGKRYERRL NLDMILSLFL NDILocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF284 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 2.7 nTPM
Expression across tissuesHPA
Tissue
- skin: 2.7 nTPM
- retina: 2.1 nTPM
- spleen: 2 nTPM
- cerebellum: 1.9 nTPM
- adrenal gland: 1.6 nTPM
- thymus: 1.6 nTPM
Single-cell type
- choroid plexus epithelial cells: 6.9 nCPM
- hepatic stellate cells: 6.5 nCPM
- megakaryocytes: 6.2 nCPM
- melanocytes: 5.5 nCPM
- oligodendrocyte progenitor cells: 5.4 nCPM
- other brain neurons: 5 nCPM
Immune cell
- NK-cell: 3.7 nTPM
- naive CD8 T-cell: 2.5 nTPM
- naive CD4 T-cell: 2.4 nTPM
- T-reg: 2.2 nTPM
- gdT-cell: 2 nTPM
- memory CD4 T-cell: 2 nTPM
Brain region
- cerebellum: 8.4 nTPM
- thalamus: 7.3 nTPM
- white matter: 7.3 nTPM
- choroid plexus: 6.9 nTPM
- cerebral cortex: 6.7 nTPM
- basal ganglia: 6.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.76
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.21
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZNF284 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF284 as an antibody target. Whether an autoantibody or antibody against ZNF284 could matter depends on whether native ZNF284 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF284 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF284 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...